Article | January 11, 2021

How Single-Use Technology Will Be Critical To The Commercialization Of Cell And Gene Therapies

Source: Avantor

By Timothy Korwan, Director, New Product Introduction, Avantor, Inc.

Scaling up cell & gene therapies from research and development to commercialization is creating a new set of challenges for manufacturers. With the urgent demand of speeding up the market reach for these life-altering innovative therapies a high risk is inherent to implement inefficient workflow processes. This article will demonstrate how adopting innovative single-use solutions for in-process sampling can have a tremendous effect in efficiency and effectiveness to the workflow. Single-use solutions continue to provide productive strategies in effectively scaling up these processes while reducing risks and costs. 

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene